Alida Ngwije
Biographic Data
| ID | 7785633 |
|---|---|
| NAME | Alida Ngwije |
| GIVEN NAMES | Alida |
| FAMILY NAME | Ngwije |
| SIGNATURE | NGWIJE A |
| AFFILIATIONS | Clinton Health Access Initiative, Kigali, Rwanda |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Rapid establishment of public sector Covid-19 test-and-treatment programmes across seven low- and middle-income countries
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia, to implement COVID-19 test-and-treat programmes at 776 health facilities, including training over 5000 staff and facilitating a donation of 11 300 courses of the oral antiviral nirmatrelvir/ritonavir for treatment. This paper describes the process of implementing COVID-19 …
Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries
With political will, modest financial investment and effective technical assistance, public sector hepatitis C virus (HCV) programmes can be established in low- and middle-income countries as a first step towards elimination. Seven countries, with support from the Clinton Health Access Initiative (CHAI) and partners, have expanded access to HCV treatment by combining programme simplification with market shaping to reduce commodity prices. CHAI ha…
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda
Several interrelated factors acted as barriers and facilitators to DAA treatment in Rwanda. Patients' and healthcare providers' perceptions were in agreement, suggesting that the impeding and enabling factors were well understood by both groups. These results can be used to enact evidence-informed interventions to help maximize the impact of DAAs as Rwanda moves towards HCV elimination
No prominent works on this page.
Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries
With political will, modest financial investment and effective technical assistance, public sector hepatitis C virus (HCV) programmes can be established in low- and middle-income countries as a first step towards elimination. Seven countries, with support from the Clinton Health Access Initiative (CHAI) and partners, have expanded access to HCV treatment by combining programme simplification with market shaping to reduce commodity prices. CHAI ha…
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda
Several interrelated factors acted as barriers and facilitators to DAA treatment in Rwanda. Patients' and healthcare providers' perceptions were in agreement, suggesting that the impeding and enabling factors were well understood by both groups. These results can be used to enact evidence-informed interventions to help maximize the impact of DAAs as Rwanda moves towards HCV elimination
Rapid establishment of public sector Covid-19 test-and-treatment programmes across seven low- and middle-income countries
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia, to implement COVID-19 test-and-treat programmes at 776 health facilities, including training over 5000 staff and facilitating a donation of 11 300 courses of the oral antiviral nirmatrelvir/ritonavir for treatment. This paper describes the process of implementing COVID-19 …
Public health (3 works) · Health care (2 works) · Hepatitis B Virus Studies (2 works) · Hepatitis C virus research (2 works) · Liver Disease Diagnosis and Treatment (2 works) · Medicine (2 works) · Nursing (2 works) · Biostatistics (1 works) · Business (1 works) · Commodity (1 works)